UHT Financials UNIVERSAL HEALTH REALTY INCOME TRUST

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated 28 h ago Overview →

Growth & profitability

Revenue has grown 4.9% per year over the past 5 years.
Net income has grown slower than revenue (-2.0% vs 4.9% per year).
Operating margin has expanded, at 35.0% in the latest year.
Free cash flow has declined 1.9% per year over the past 5 years.

Financial health

Total debt ($375M) exceeds cash ($7M); net debt is $368M.
Total debt has grown in line with revenue (4.9% vs 4.9% per year).
Total debt is 5.9× EBITDA.

Shareholder returns

Dividends have been paid for 15 consecutive years, consuming 233.0% of earnings.
The dividend has grown 1.6% per year over the past 5 years.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	FCF	Total debt	Cash
2025	$99M	$18M	0.0%	35.0%	—	$375M	$7M
2024	$99M	$19M	0.0%	37.2%	—	$368M	$7M
2023	$96M	$15M	0.0%	32.8%	$35M	$360M	$8M
2022	$91M	$21M	0.0%	33.8%	$33M	$343M	$8M
2021	$84M	$109M	0.0%	34.3%	$35M	$329M	$23M
2020	$78M	$19M	0.0%	33.3%	$42M	$295M	$6M
2019	$77M	$19M	0.0%	33.4%	$38M	$274M	$6M
2018	$76M	$24M	0.0%	35.0%	$39M	$262M	$5M
2017	$72M	$46M	0.0%	33.2%	$37M	$257M	$3M
2016	$67M	$17M	0.0%	33.0%	-$20M	$316M	$4M
2015	$64M	$24M	0.0%	32.3%	—	$252M	$4M
2014	$60M	$52M	0.0%	31.9%	—	$213M	$4M
2013	$54M	$13M	0.0%	34.2%	$27M	$199M	$3M
2012	$54M	$19M	0.0%	30.3%	—	$197M	$3M
2011	$29M	$74M	0.0%	29.6%	—	—	$12M

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	FCF	Total debt	Cash
Mar '26	$25M	$5M	0.0%	36.5%	—	—	$7M
Dec '25	$24M	$4M	0.0%	34.7%	—	$375M	$7M
Sep '25	$25M	$4M	0.0%	33.2%	—	—	$7M
Jun '25	$25M	$4M	0.0%	35.6%	—	—	$7M
Mar '25	$25M	$5M	0.0%	36.8%	—	—	$7M
Dec '24	$25M	$5M	0.0%	37.6%	—	$368M	$7M
Sep '24	$24M	$4M	0.0%	34.7%	—	—	$6M
Jun '24	$25M	$5M	0.0%	38.7%	—	—	$6M
Mar '24	$25M	$5M	0.0%	37.6%	—	—	$8M
Dec '23	$24M	$4M	0.0%	33.5%	$10M	$360M	$8M
Sep '23	$24M	$4M	0.0%	33.1%	—	—	$8M
Jun '23	$24M	$3M	0.0%	31.0%	—	—	$9M
Mar '23	$23M	$4M	0.0%	33.5%	—	—	$8M
Dec '22	$24M	$6M	0.0%	36.2%	$12M	$343M	$8M
Sep '22	$22M	$5M	0.0%	33.1%	$10M	—	$8M
Jun '22	$22M	$5M	0.0%	32.7%	$13M	—	$8M
Mar '22	$22M	$5M	0.0%	33.3%	-$2M	—	$9M
Dec '21	$21M	$92M	0.0%	34.5%	$12M	$329M	$23M
Sep '21	$21M	$5M	0.0%	34.4%	$11M	—	$9M
Jun '21	$21M	$7M	0.0%	33.2%	—	—	$10M

Valuation over time

How the market has priced UHT against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has risen from 31.6× (Mar '23) to 32.8× (Jun '26).
The price-to-sales ratio has fallen from 7.4× (Mar '23) to 5.8× (Jun '26).
The dividend yield has risen from 5.9% (Mar '23) to 7.1% (Jun '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is UHT growing its revenue and profit?

Over the past 5 years, UNIVERSAL HEALTH REALTY INCOME TRUST's revenue has grown 4.9% per year, and net income declined 2.0% per year. These are computed facts, not advice.

How much debt does UHT have?

As of FY2025, UNIVERSAL HEALTH REALTY INCOME TRUST reported $375M of total debt against $7M of cash.

What is UHT's profit margin?

In FY2025, gross margin was —, operating margin 35.0%, and net margin 17.8%.

What is UHT's P/E ratio?

As of Jun '26, UNIVERSAL HEALTH REALTY INCOME TRUST traded at a price-to-earnings ratio of about 32.8× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.